KERA Antikörper (C-Term)
Kurzübersicht für KERA Antikörper (C-Term) (ABIN953035)
Target
Alle KERA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 227-257, C-Term
-
Spezifität
- This antibody recognizes Human Keratocan (C-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 227-257 amino acids from the C-terminal region of human Keratocan Genename: KERA
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KERA (Keratocan (KERA))
-
Andere Bezeichnung
- Keratocan
-
Hintergrund
- The protein encoded by this gene is a keratan sulfate proteoglycan that is involved in corneal transparency. Defects in this gene are a cause of autosomal recessive cornea plana 2 (CNA2).Synonyms: KERA, KTN, Keratan sulfate proteoglycan keratocan, Keratocan, SLRR2B
-
Molekulargewicht
- 40509 Da
-
Gen-ID
- 11081
-
NCBI Accession
- NP_008966
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-